Skip to main content
. 2021 Dec 1;8:704501. doi: 10.3389/fcvm.2021.704501

Table 4.

Univariate and multivariate adjusted logistic regression analysis of HMGCR gene SNPs and the risk of PTVD.

Polymorphism Model Crude Multivariate*
OR 95% CI P OR 95% CI P
rs12916 T>C Codominant (TT/TC/CC) 1.35 1.15–1.59 <0.001 1.38 1.17–1.63 <0.001
Recessive (CC/TC+TT) 1.37 1.05–1.82 0.024 1.43 1.08–1.90 0.013
Dominance (TT/TC+CC) 1.64 1.27–2.12 <0.001 1.68 1.29–2.18 <0.001
rs2303151 C>T Codominant (CC/CT/TT) 1.12 0.90–1.39 0.320 1.12 0.91–1.40 0.297
Recessive (TT/CT+TT) 1.93 0.96–4.30 0.081 1.95 0.97–4.36 0.077
Dominance (CC/CT+TT) 1.06 0.83–1.36 0.641 1.07 0.83–1.37 0.610
rs4629571 A>G Codominant (AA/AG/GG) 1.12 0.90–1.39 0.320 1.00 0.76–1.34 0.980
Recessive (GG/AG+GG) 1.27 0.43–4.60 0.686 1.17 0.39–4.26 0.79
Dominance (GG/AA+AG) 0.99 0.73–1.35 0.945 0.99 0.73–1.36 0.967
*

Adjusted for age and sex. HMGCR, 3-hydroxy-3-methylglutaryl-coenzyme A reductase; PTVD, premature triple-vessel disease; OR, odds ratio; CI, confidence interval.